REPS from some of the giants of the pharmaceutical world travelled to Bradford to take part in an annual event dedicated to enrolling greater numbers of NHS patients into pioneering clinical trials.
Senior representatives from GSK, AstraZeneca, Sanofi Aventis and IQVIA met with clinical and research staff at Bradford Teaching Hospital NHS Foundation Trust (BTHFT).
More than 50,000 Bradfordians are currently actively involved in Bradford Institute for Health Research's studies but it has a five year goal to increase this to 100,000.
Dr Dinesh Saralaya, BTHFT’s associate director of research, said: "Bradford maintains a tradition of bringing high-quality research and innovation and cutting-edge technology to the patients of Bradford."
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here